|
|
Volumn 107, Issue 2, 1999, Pages 180-181
|
|
Treatment of hepatitis C: A decision that needs careful consideration
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTIINFECTIVE AGENT;
ANTIVIRUS AGENT;
INTERFERON;
RIBAVIRIN;
VIRUS RNA;
DRUG CHOICE;
EDITORIAL;
GENOTYPE;
HEPATITIS C;
HUMAN;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT PLANNING;
VIRUS LOAD;
ANTIVIRAL AGENTS;
DISEASE PROGRESSION;
DNA, VIRAL;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
INTERFERONS;
RIBAVIRIN;
RISK;
|
|
EID: 0032817176
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(99)00188-6 Document Type: Editorial |
|
Times cited : (1)
|
|
References (10)
|
